Related references
Note: Only part of the references are listed.AZ2158 is a more potent formyl peptide receptor 1 inhibitor than the commonly used peptide antagonists in abolishing neutrophil chemotaxis
Huamei Forsman et al.
BIOCHEMICAL PHARMACOLOGY (2023)
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2)Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders
Margherita Mastromarino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Structural basis for recognition of N-formyl peptides as pathogen-associated molecular patterns
Geng Chen et al.
NATURE COMMUNICATIONS (2022)
Inflammation and Gastric Cancer
Aunchalee Jaroenlapnopparat et al.
DISEASES (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm
Yoshiaki Nakamura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
Yolla Haibe et al.
FRONTIERS IN ONCOLOGY (2020)
The Contribution of Chemoattractant GPCRs, Formylpeptide Receptors, to Inflammation and Cancer
Weiwei Liang et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
The G-Protein Coupled Formyl Peptide Receptors and Their Role in the Progression of Digestive Tract Cancer
Cuimeng Tian et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists
Margherita Mastromarino et al.
MEDCHEMCOMM (2019)
Formyl-Peptide Receptors in Infection, Inflammation, and Cancer
Elisabeth Weiss et al.
TRENDS IN IMMUNOLOGY (2018)
The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition
Hui-Qiong He et al.
MOLECULES (2017)
Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways
Nella Prevete et al.
ONCOIMMUNOLOGY (2017)
The Expression of Formyl Peptide Receptor 1 is Correlated with Tumor Invasion of Human Colorectal Cancer
Shu-Qin Li et al.
SCIENTIFIC REPORTS (2017)
4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists
Liliya N. Kirpotina et al.
BIOCHEMICAL PHARMACOLOGY (2017)
The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis
Igor Snapkov et al.
BMC CANCER (2016)
The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis
N. Prevete et al.
ONCOGENE (2015)
Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones
Igor A. Schepetkin et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Discovery and SAR study of hydroxyacetophenone derivatives as potent, non-steroidal farnesoid X receptor (FXR) antagonists
Peng Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Molecular Mechanics
Kenno Vanommeslaeghe et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Inhibition of formyl peptide receptor in high-grade astrocytoma by CHemotaxis Inhibitory Protein of S. aureus
J. C. Boer et al.
BRITISH JOURNAL OF CANCER (2013)
Lead optimisation of pyrazoles as novel FPR1 antagonists
Andrew D. Morley et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma
Mingyong Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Polymorphisms of the formylpeptide receptor gene (FPR1) and susceptibility to stomach cancer in 1531 consecutive autopsy cases
Tatsuro Otani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Discovery of small molecule human FPR1 receptor antagonists
John Unitt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Helicobacter pylori Hp(2-20) Promotes Migration and Proliferation of Gastric Epithelial Cells by Interacting with Formyl Peptide Receptors In Vitro and Accelerates Gastric Mucosal Healing In Vivo
Amato de Paulis et al.
JOURNAL OF IMMUNOLOGY (2009)
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
R. D. Ye et al.
PHARMACOLOGICAL REVIEWS (2009)
Mycobacteria Attenuate Nociceptive Responses by Formyl Peptide Receptor Triggered Opioid Peptide Release from Neutrophils
Heike L. Rittner et al.
PLOS PATHOGENS (2009)
Formyl peptide receptors: A promiscuous subfamily of G protein-coupled receptors controlling immune responses
Isabelle Migeotte et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Ligand recognition and activation of formyl peptide receptors in neutrophils
Huamei Fu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Formylpeptide receptor FPR and the rapid growth of malignant human gliomas
Y Zhou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Cyclosporins:: Structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor
F Loor et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
